How Do Insurers Decide What Medicines to Pay For? | NBC New York

How Do Insurers Decide What Medicines to Pay For?

Insurers largely use pharmacy benefits managers to set up the lists that determine how much a patient ends up paying

    processing...

    NEWSLETTERS

    The White House and Republican lawmakers spent Tuesday defending the proposed replacement for the Affordable Care Act after a report released by the Congressional Budget Office predicted a loss in coverage for 24 million Americans should the American Health Care Act pass into law. 

    (Published Tuesday, March 14, 2017)

    How do insurance companies decide what medicines to pay for and when to pay for them?

    Insurers and other payers look first at how well the drug works — not its cost — when they decide whether to cover the latest treatments, according to the nation's largest pharmacy benefits manager, Express Scripts.

    Man Sees Vera Wang Diamond Ring on Sidewalk, Finds Its Owner

    [NATL] Man Finds Vera Wang Diamond Engagement Ring on Sidewalk, Tracks Down Its Owner

    Imagine looking down and finding a pristine diamond ring lying on the sidewalk. That was how Glenn Weddell found a Vera Wang diamond ring one afternoon in Sacramento, California. But instead of keeping it, Weddell hunted down the distraught owner to return the ring in a happy reunion. His method involved posting a sign to a tree downtown and hoping for the best. 

    (Published Thursday, April 27, 2017)

    The price patients eventually pay gets determined later, when an insurance company or pharmacy benefits manager decides where a drug fits on a list of covered treatments called a formulary.

    The cost of prescription drugs has become a growing source of concern with doctors and patients, but it's not a factor considered by an independent committee used by Express Script to determine coverage of a new drug, Chief Medical Officer Dr. Steve Miller said.

    That committee — 15 doctors and a pharmacist — reviews the information that federal regulators used to approve a drug and then decides whether it should be covered.

    Some payer coverage decisions come with qualifications like a requirement that patients meet specific criteria or try other treatments first. That can limit patient access. Doctors say some patients have had trouble getting a new cholesterol-lowering drug, Repatha, that costs $14,000 a year, because of the restrictions.

    Flyer Protections on Overbooked Plane Flights

    [NATL] Flyer Protections on Overbooked Plane Flights

    NBC reports on the steps that flyers and travelers can take to protect themselves, and their vacation, from an overbooked flight.

    (Published Wednesday, April 26, 2017)

    Insurers largely use pharmacy benefits managers to set up the lists that determine how much a patient ends up paying. Some lists are divided into tiers, with drugs on the bottom generally being generic or least expensive. Those on the highest tier might include specialty medicines that could cost the patient hundreds of dollars even with coverage.

    Whether a drug even gets on the list can depend on whether a similar medicine is already in the market. When the ground-breaking hepatitis C treatments Sovaldi and Harvoni from Gilead Sciences debuted a few years ago, Express Scripts had to include them. They cost more than $80,000 for a course of treatment, but the drugs essentially cure a debilitating disease and they had no competition.

    But once the drugmaker AbbVie produced a third option, Viekira Pak, with a similar cure rate, Express Scripts was able to negotiate a price discount and switched to covering only Viekira Pak.

    The nation's two largest pharmacy benefits managers, Express Scripts and CVS Health Corp., both say they cover Repatha.

    New Artificial Wombs Stimulates Mom for Preemies

    [NATL] New Artificial Wombs Stimulates Mom for Preemies

    A new invention from the Children's Hospital of Philadelphia may soon care for extremely premature babies. Artificial wombs stimulate an environment similar to a mother's womb - a method that researchers say is gentler than ventilators and incubators. 

    (Published Wednesday, April 26, 2017)